This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Glaxo Group Limited. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Martin John Cassidy: Innovator in Monoclonal Antibodies
Introduction
Martin John Cassidy is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of immunology, particularly through his work on monoclonal antibodies. His innovative approach has the potential to impact the treatment of various diseases.
Latest Patents
Martin John Cassidy holds a patent for "Chimeric and humanised monoclonal antibodies against Interleukin-13." This invention focuses on immunoglobulins, specifically antibodies that bind to human Interleukin 13 (hIL-13). The antibodies developed through this patent may be utilized in treating diseases responsive to the modulation of the interaction between hIL-13 and the human IL-13 receptor. Such diseases include severe asthma, atopic dermatitis, COPD, and various fibrotic diseases. The patent also discloses pharmaceutical compositions comprising these antibodies and methods of manufacture.
Career Highlights
Martin is associated with Glaxo Group Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic settings.
Collaborations
Some of his coworkers include Claire Ashman and Jonathan Henry Ellis, who contribute to the collaborative environment that fosters innovation within their projects.
Conclusion
Martin John Cassidy's contributions to the field of monoclonal antibodies exemplify the impact of innovative research on healthcare. His work holds promise for improving treatment options for various diseases.